KEY PRODUCTS
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
01 1Noramco
01 1NALTREXONE HYDROCHLORIDE DRUG SUBSTANCE
01 1U.S.A
01 1Active
01 1Complete
Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
GDUFA
DMF Review : Complete
Rev. Date : 2014-01-14
Pay. Date : 2013-12-20
DMF Number : 23325
Submission : 2009-12-01
Status : Active
Type : II
20
Noramco Llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Noramco is a partner to the pharmaceutical industry for controlled substance development & manufacturing.
One of their notable products is NALTREXONE HYDROCHLORIDE DRUG SUBSTANCE, with a corresponding US DMF Number 23325.
Remarkably, this DMF maintains an Active status since its submission on December 01, 2009, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 14, 2014, and payment made on December 20, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II
